
1. expert rev vaccines. 2017 jan;16(1):73-80. epub 2016 nov 16.

a potent adjuvant effect cd1d-binding nkt cell ligand human immune system
mice.

li x(1), huang j(1), kaneko i(2), zhang m(1)(3), iwanaga s(2), yuda m(2), tsuji
m(1).

author information: 
(1)a hiv malaria vaccine program, aaron diamond aids research center ,
affiliate rockefeller university , new york , ny , usa.
(2)b department medical zoology , mie university graduate school medicine ,
tsu , mie , japan.
(3)c department pathology , new york university school medicine , new york 
, ny , usa.

objectives: cd1d-binding invariant natural killer (inkt)-cell stimulatory
glycolipid, namely 7dw8-5, shown enhance efficacy of
radiation-attenuated sporozoites (ras)-based malaria vaccine mice. the
current study, aim determine whether 7dw8-5 display potent adjuvant
effect human immune system (his) mice.
methods: his-a2/hcd1d mice, possess functional human inkt cells and
cd8+ t cells, generated transduction nsg mice with
adeno-associated virus serotype 9 expressing genes encode human cd1d
molecules hla-a*0201, followed engraftment human hematopoietic stem
cells. magnitudes human inkt-cell response 7dw8-5 and
hla-a*0201-restricted human cd8+ t-cell response human malaria antigen 
in his-a2/hcd1d mice determined using human cd1d tetramer human
hla-a*0201 tetramer, respectively.
results: found 7dw8-5 stimulates human inkt cells his-a2/hcd1d mice,
as well derived his-a2/hcd1d mice vitro. also found that
7dw8-5 significantly increases level human malarial antigen-specific
hla-a*0201-restricted human cd8+ t-cell response his-a2/hcd1d mice.
conclusions: study indicates 7dw8-5 display potent adjuvant effect
on ras vaccine-induced anti-malarial immunity augmenting malaria-specific
human cd8+ t-cell response.

doi: 10.1080/14760584.2017.1256208 
pmcid: pmc5526659
pmid: 27801602  [indexed medline]

